The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Open accessAbstract
Current drug development in oncology is non-selective as it typically focuses on pathways essential for the survival of all dividing cells. The unique metabolic profile of cancer, which is characterized by increased glycolysis and suppressed mitochondrial glucose oxidation (GO) provides cancer cells with a proliferative advantage, conducive with apoptosis resistance and even increased angiogenesis. Recent evidence suggests that targeting the cancer-specific metabolic and mitochondrial remodeling may offer selectivity in cancer treatment. Pyruvate dehydrogenase kinase (PDK) is a mitochondrial enzyme that is activated in a variety of cancers and results in the selective inhibition of pyruvate dehydrogenase, a complex of enzymes that converts cytosolic pyruvate to mitochondrial acetyl-CoA, the substrate for the Krebs' cycle. Inhibition of PDK with either small interfering RNAs or the orphan drug dichloroacetate (DCA) shifts the metabolism of cancer cells from glycolysis to GO and reverses the suppression of mitochondria-dependent apoptosis. In addition, this therapeutic strategy increases the production of diffusible Krebs' cycle intermediates and mitochondria-derived reactive oxygen species, activating p53 or inhibiting pro-proliferative and pro-angiogenic transcription factors like nuclear factor of activated T cells and hypoxia-inducible factor 1α. These effects result in decreased tumor growth and angiogenesis in a variety of cancers with high selectivity. In a small but mechanistic clinical trial in patients with glioblastoma, a highly aggressive and vascular form of brain cancer, DCA decreased tumor angiogenesis and tumor growth, suggesting that metabolic-targeting therapies can be translated directly to patients. More recently, the M2 isoform of pyruvate kinase (PKM2), which is highly expressed in cancer, is associated with suppressed mitochondrial function. Similar to DCA, activation of PKM2 in many cancers results in increased mitochondrial function and decreased tumor growth. Therefore, reversing the mitochondrial suppression with metabolic-modulating drugs, like PDK inhibitors or PKM2 activators holds promise in the rapidly expanding field of metabolic oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“Similarly, herceptin, an antibody that inhibits human epidermal growth factor receptor 2 (HER2) on HER2-positive breast cancers (Eisenhauer, 2001; Slamon et al., 2001) is also selective and effective, but like Gleevec this is an exception in oncology.”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Mitofusin 2 tethers endoplasmic reticulum to mitochondria
de Brito, O. M., & Scorrano, L. (2008) · Nature · doi:10.1038/nature07534 · Cited by 2,442
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · cited 1×
“Remarkably, similar to DCA, inhibition of LDH-A by short-hairpin RNAs increased mitochondrial activity, depolarized mitochondria, inducing apoptosis, and decreasing tumor growth in vitro and in vivo, once again mimicking DCA (Fantin et al., 2006).”
BackgroundNFAT proteins: key regulators of T-cell development and function
Macian, F. (2005) · Nature Reviews Immunology · doi:10.1038/nri1632 · Cited by 1,569
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Self-citationAkt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
PI3K-Akt pathway: Its functions and alterations in human cancer
Osaki, M., Oshimura, M., & Ito, H. (2004) · Apoptosis · doi:10.1023/b:appt.0000045801.15585.dd · Cited by 1,264
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Huang, L. E., Arany, Z., Livingston, D. M., & Bunn, H. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32253 · Cited by 1,190
Mitochondrial Membrane Potential in Living Cells
Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,037
The mitochondrion in apoptosis: how Pandora's box opens
Zamzami, N., & Kroemer, G. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048073 · Cited by 1,028
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., & Hay, N. (2001) · Genes & Development · doi:10.1101/gad.889901 · Cited by 961
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959 · cited 2×
“In other words, loss of p53, one of the most common molecular abnormalities in cancer, contributes to the glycolytic environment in cancer promoting glycolysis and inhibiting mitochondrial GO and function (Burns and Richter, 2008; Vousden and Ryan, 2009).”
BackgroundPyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Anastasiou, D., Yu, Y., Israelsen, W. J., Jiang, J.-K., Boxer, M. B., Hong, B. S., Tempel, W., Dimov, S., Shen, M., Jha, A., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1060 · Cited by 816
Metabolic Modulation of Glioblastoma with Dichloroacetate
Michelakis, E. D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E., Maguire, C., Gammer, T.-L., Mackey, J. R., Fulton, D., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000677 · Cited by 720
Self-citationSamudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
Multifaceted roles of glycolytic enzymes
Kim, J.-W., & Dang, C. V. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.005 · Cited by 682
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
Michelakis, E. D., Webster, L., & Mackey, J. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604554 · Cited by 656
Self-citationGlycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647 · cited 2×
“For example, p53 inhibits the expression of the glycolytic enzyme phosphoglycerate mutase (Kondoh et al., 2005), while increasing the expression of the glycolytic inhibitor Tp53-induced glycolysis and apoptosis regulator (TIGAR; Bensaad et al.”
BackgroundEvidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
Vander Heiden, M. G., Locasale, J. W., Swanson, K. D., Sharfi, H., Heffron, G. J., Amador-Noguez, D., Christofk, H. R., Wagner, G., Rabinowitz, J. D., Asara, J. M., et al. (2010) · Science · doi:10.1126/science.1188015 · Cited by 635
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2010) · Nature · doi:10.1038/nature09132 · Cited by 613
Duchen, M. R. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.001aa.x · Cited by 610
PACS‐2 controls endoplasmic reticulum–mitochondria communication and Bid‐mediated apoptosis
Simmen, T., Aslan, J. E., Blagoveshchenskaya, A. D., Thomas, L., Wan, L., Xiang, Y., Feliciangeli, S. F., Hung, C., Crump, C. M., & Thomas, G. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600559 · Cited by 592
Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex
BOWKER-KINLEY, M. M., DAVIS, I. W., WU, P., HARRIS, A. R., & POPOV, M. K. (1998) · Biochemical Journal · doi:10.1042/bj3290191 · Cited by 565
Madesh, M., & Hajnóczky, G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105057 · Cited by 538
Bourdon, A., Minai, L., Serre, V., Jais, J.-P., Sarzi, E., Aubert, S., Chrétien, D., de Lonlay, P., Paquis-Flucklinger, V., Arakawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2040 · Cited by 531
Acute Oxygen-Sensing Mechanisms
Weir, E. K., López-Barneo, J., Buckler, K. J., & Archer, S. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050002 · Cited by 492
The pharmacology of dichloroacetate
Stacpoole, P. W. (1989) · Metabolism · doi:10.1016/0026-0495(89)90051-6 · Cited by 484
Fuertes, M., Castilla, J., Alonso, C., & Pérez, J. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368484 · Cited by 432
Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism.
Boss, O., Hagen, T., & Lowell, B. B. (2000) · Diabetes · doi:10.2337/diabetes.49.2.143 · Cited by 414
Bernardi, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00041-2 · Cited by 413
Pastorino, J. G., Hoek, J. B., & Shulga, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1925 · Cited by 398
Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells
McFate, T., Mohyeldin, A., Lu, H., Thakar, J., Henriques, J., Halim, N. D., Wu, H., Schell, M. J., Tsang, T. M., Teahan, O., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801765200 · Cited by 385
Glucose Catabolism in Cancer Cells
Mathupala, S. P., Rempel, A., & Pedersen, P. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108181200 · Cited by 373
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Dhar, S., & Lippard, S. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912276106 · Cited by 369
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
Kaufmann, P., Engelstad, K., Wei, Y., Jhung, S., Sano, M. C., Shungu, D. C., Millar, W. S., Hong, X., Gooch, C. L., Mao, X., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000196641.05913.27 · Cited by 365
Bonnet, S., Rochefort, G., Sutendra, G., Archer, S. L., Haromy, A., Webster, L., Hashimoto, K., Bonnet, S. N., & Michelakis, E. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610467104 · Cited by 364
Self-citationMacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359
Why is cancer drug discovery so difficult?
Kamb, A., Wee, S., & Lengauer, C. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2155 · Cited by 339
Wartenberg, M., Ling, F. C., Müschen, M., Klein, F., Acker, H., Gassmann, M., Petrat, K., Pütz, V., Hescheler, J., & Sauer, H. (2003) · The FASEB Journal · doi:10.1096/fj.02-0358fje · Cited by 287
Controlled Clinical Trial of Dichloroacetate for Treatment of Congenital Lactic Acidosis in Children
Stacpoole, P. W., Kerr, D. S., Barnes, C., Bunch, S. T., Carney, P. R., Fennell, E. M., Felitsyn, N. M., Gilmore, R. L., Greer, M., Henderson, G. N., et al. (2006) · Pediatrics · doi:10.1542/peds.2005-1226 · Cited by 259
Hexokinase II: The Integration of Energy Metabolism and Control of Apoptosis
Pastorino, J., & Hoek, J. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457269 · Cited by 257
Activation of K+channels: an essential pathway in programmed cell death
Remillard, C. V., & Yuan, J. X.-J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2003 · Cited by 251
p53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2
Contractor, T., & Harris, C. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1215 · Cited by 245
The Role of Nogo and the Mitochondria–Endoplasmic Reticulum Unit in Pulmonary Hypertension
Sutendra, G., Dromparis, P., Wright, P., Bonnet, S., Haromy, A., Hao, Z., McMurtry, M. S., Michalak, M., Vance, J. E., Sessa, W. C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002194 · Cited by 240
Self-citationGlucose Catabolism in Cancer Cells
Mathupala, S. P., Heese, C., & Pedersen, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22776 · Cited by 231
Sun, R. C., Fadia, M., Dahlstrom, J. E., Parish, C. R., Board, P. G., & Blackburn, A. C. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0435-9 · Cited by 226
Dichloroacetate induces apoptosis in endometrial cancer cells
Wong, J. Y. Y., Huggins, G. S., Debidda, M., Munshi, N. C., & De Vivo, I. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.038 · Cited by 219
Metabolic enzymes as oncogenes or tumor suppressors
Thompson, C. B. (2009) · New England Journal of Medicine · doi:10.1056/nejme0810213 · Cited by 213
Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance
SACK, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.07.010 · Cited by 188
Sutendra, G., Dromparis, P., Kinnaird, A., Stenson, T. H., Haromy, A., Parker, J. M. R., McMurtry, M. S., & Michelakis, E. D. (2013) · Oncogene · doi:10.1038/onc.2012.198 · Cited by 184
Self-citationReactive oxygen species: A radical role in development?
Hernández-García, D., Wood, C. D., Castro-Obregón, S., & Covarrubias, L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.020 · Cited by 184
Cao, W., Yacoub, S., Shiverick, K. T., Namiki, K., Sakai, Y., Porvasnik, S., Urbanek, C., & Rosser, C. J. (2008) · The Prostate · doi:10.1002/pros.20788 · Cited by 181
Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells
Madhok, B. M., Yeluri, S., Perry, S. L., Hughes, T. A., & Jayne, D. G. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605701 · Cited by 180
Kluza, J., Corazao-Rozas, P., Touil, Y. S., Jendoubi, M., Maire, C., Guerreschi, P., Jonneaux, A., Ballot, C., Balayssac, S., Valable, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0979 · Cited by 174
Vanadate Induces p53 Transactivation through Hydrogen Peroxide and Causes Apoptosis
Huang, C., Zhang, Z., Ding, M., Li, J., Ye, J., Leonard, S. S., Shen, H.-M., Butterworth, L., Lu, Y., Costa, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005366200 · Cited by 173
Effect of Altered Redox States on Expression and DNA-Binding Activity of Hypoxia-Inducible Factor 1
Wang, G. L., Jiang, B. H., & Semenza, G. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2005 · Cited by 172
Efficacy of Dichloroacetate as a Lactate-Lowering Drug
Stacpoole, P. W., Nagaraja, N. V., & Hutson, A. D. (2003) · Journal of Clinical Pharmacology · doi:10.1177/0091270003043007001 · Cited by 171
p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1)
Schmid, T., Zhou, J., Köhl, R., & Brüne, B. (2004) · Biochemical Journal · doi:10.1042/bj20031299 · Cited by 153
Xie, S., Wang, Q., Wu, H., Cogswell, J. P., Luo, L., Jhanwar‐Uniyal, M., & Dai, W. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104157200 · Cited by 137
Selection of cancer cells with repressed mitochondria triggers colon cancer progression
Sánchez‐Aragó, M., Chamorro, M., & Cuezva, J. M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq012 · Cited by 134
CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation
Burns, D. M., & Richter, J. D. (2008) · Genes & Development · doi:10.1101/gad.1697808 · Cited by 134
The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation
Wang, S., Leonard, S. S., Ye, J., Ding, M., & Shi, X. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.3.c868 · Cited by 123
The role of mitochondria in pulmonary vascular remodeling
Dromparis, P., Sutendra, G., & Michelakis, E. D. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0670-x · Cited by 114
Self-citationKnoechel, T. R., Tucker, A. D., Robinson, C. M., Phillips, C., Taylor, W. S., Bungay, P. J., Kasten, S. A., Roche, T. E., & Brown, D. G. (2005) · Biochemistry · doi:10.1021/bi051402s · Cited by 111
Karshovska, E., Zernecke, A., Sevilmis, G., Millet, A., Hristov, M., Cohen, C. D., Schmid, H., Krötz, F., Sohn, H., Klauß, V., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.151050 · Cited by 102
Kaluzová, M., Kaluz, Š., Lerman, M. I., & Stanbridge, E. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5757-5766.2004 · Cited by 100
Okamura, S., Ng, C. C., Koyama, K., Takei, Y., Arakawa, H., Monden, M., & Nakamura, Y. (1999) · PubMed · Cited by 95
Fantin, V. R., St‐Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.011 · Cited by 92
New Aspects of Mitochondrial Uncoupling Proteins (UCPs) and Their Roles in Tumorigenesis
Robbins, D. F., & Zhao, Y. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12085285 · Cited by 78
Kumar, A., Kant, S., & Singh, S. M. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.06.005 · Cited by 67
From the Molecule to the Clinic — Inhibiting HER2 to Treat Breast Cancer
Eisenhauer, E. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441110 · Cited by 64
Mitochondrial Membrane Potential In Living Cells
Chen, L. (1988) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.4.1.155 · Cited by 61
Curbing cancer's sweet tooth: Is there a role for MnSOD in regulation of the Warburg effect?
Holley, A. K., Dhar, S. K., & Clair, D. K. S. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.07.104 · Cited by 41
Review of the Pharmacologic and Therapeutic Effects of Diisopropylammonium Dichloroacetate (DIPA)
Stacpoole, P. W. (1969) · The Journal of Clinical Pharmacology · doi:10.1177/009127006900900502 · Cited by 35
Anaplerotic reactions in tumour proliferation and apoptosis
Quash, G., Fournet, G., & Reichert, U. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00106-0 · Cited by 12
Randle (1998) · doi:10.1002/(sici)1099-0895(199812)14:4<263::aid-dmr233>3.0.co;2-c
Cited by
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
Gerriets, V. A., Kishton, R. J., Nichols, A. G., Macintyre, A. N., Inoue, M., Ilkayeva, O., Winter, P. S., Liu, X., Priyadharshini, B., Slawinska, M. E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76012 · Cited by 731
The pyruvate dehydrogenase complexes: structure-based function and regulation
Patel, M. S., Nemeria, N. S., Furey, W., & Jordan, F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.563148 · Cited by 674
The Warburg effect then and now: From cancer to inflammatory diseases
Palsson‐McDermott, E. M., & O'Neill, L. A. J. (2013) · BioEssays · doi:10.1002/bies.201300084 · Cited by 537
The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility
Zhang, S., Hulver, M. W., McMillan, R. P., Cline, M. A., & Gilbert, E. R. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-10 · Cited by 450
Metadata
- Authors
- Sutendra, G., & Michelakis, E. D.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 3
- Pages
- 38-38
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2074171009
- Cited by
- 262
- References
- 96
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.